The Serotonin 5-HT2A Receptors Antagonist M100907 Prevents Impairment in Attentional Performance by NMDA Receptor Blockade in the Rat Prefrontal Cortex
The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.
Abstract
We investigated whether 5-HT2A receptors contribute to the control of attentional performance by glutamate NMDA receptor mechanisms in the medial prefrontal cortex (mPFC). We examined the effects of NMDA receptor blockade in the mPFC on attentional performance by infusing a competitive glutamate NMDA receptor antagonist, 3-(R)-2-carboxypiperazin-4-propyl-1-phosphonic acid (CPP) into the mPFC of rats performing a task of divided and sustained visual attention. The five-choice serial reaction time task provides indices of attentional functioning (% correct responses), executive control (measured by anticipatory and perseverative responses) and speed. A dose of 10 ng CPP injected bilaterally into the mPFC increased anticipatory and perseverative responding; 50 ng reduced accuracy. Increasing the stimulus duration alleviated the CPP-induced accuracy deficit but did not reduce its effects on anticipatory and perseverative responses. CPP at 50 ng caused motor hyperactivity whereas lower doses had no effect. [R-(+)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine-methanol] (M100907) (M100907), a 5-HT2A receptor antagonist, injected subcutaneously at 10 and 40 microg/kg, had no effect on accuracy but dose dependently reversed the impairment induced by 50 ng CPP. Both doses of M100907 completely abolished CPP-induced anticipatory but not perseverative over-responding. At the dose of 40 microg/kg M100907 reversed CPP-induced motor hyperactivity. This study provides evidence that the prefronto-cortical glutamate NMDA system may make an important contribution to the control of attention and executive functions. It also indicates that 5-HT2A receptors may serve to optimize attentional selectivity and improve some aspects of executive control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In non-stressed animals both competitive NMDA-R antagonists, such as (R)-CPP (Mirjana et al 2004) and non-competitive NMDA-R antagonists such as dizocilpine, and phencyclidine (Higgins et al 2003, Le Pen et al 2003) injected into the mPFC produce pronounced attentional performance deficits as measured by increase in omissions and latency for correct detection in the 5-CSRTT.”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Mirjana et al 2004
In the citing paper
“For example, (R)-CPP produced increased premature responding, indicating deficits in response inhibition (Mirjana et al 2004).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Mirjana et al 2004
In the citing paper
“Injecting M100907 subcutaneously reverses CPP-induced decreases in response inhibition (Mirjana et al 2004).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Mirjana et al 2004
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 26,755
Statistical Principles in Experimental Design
Myers, J. L., & Winer, B. J. (1964) · The American Journal of Psychology · doi:10.2307/1419292 · Cited by 8,058
Specific impairments of planning
Shallice, T. (1982) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1982.0082 · Cited by 3,741
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Exploring the Central Executive
Baddeley, A. (1996) · The Quarterly Journal of Experimental Psychology Section A · doi:10.1080/713755608 · Cited by 2,390
(1995) · Choice Reviews Online · doi:10.5860/choice.32-5931 · Cited by 2,311
Fuster, J. M. (1997) · Cited by 2,244
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Corbetta, M., Miezin, F., Dobmeyer, S., Shulman, G., & Petersen, S. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-08-02383.1991 · Cited by 1,588
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282
Goldman-Rakic, P. S. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0129 · Cited by 1,072
The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia
Meltzer, H. Y., & McGurk, S. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033376 · Cited by 1,020
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
Zahrt, J., Taylor, J. R., Mathew, R. G., & Arnsten, A. F. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08528.1997 · Cited by 796
Serotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
Coordination of Actions and Habits in the Medial Prefrontal Cortex of Rats
Killcross, S. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.4.400 · Cited by 748
Information Processing and Attention Dysfunctions in Schizophrenia
Braff, D. L. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.233 · Cited by 738
Carli, M., Robbins, T. W., Evenden, J. L., & Everitt, B. J. (1983) · Behavioural Brain Research · doi:10.1016/0166-4328(83)90138-9 · Cited by 736
The Role of Serotonin in Antipsychotic Drug Action
Meltzer, H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00046-9 · Cited by 662
Frith, C. D. (1987) · Psychological Medicine · doi:10.1017/s0033291700025873 · Cited by 655 · cited 2×
“Cognitive deficits, including attention disorders and deficits in executive functions, are a central feature of schizophrenia (Frith, 1987; Kay and Sevy, 1990; Braff, 1993).”
BackgroundOwen, A. M., Roberts, A. C., Hodges, J. R., & Robbins, T. W. (1993) · Brain · doi:10.1093/brain/116.5.1159 · Cited by 639
Excitatory amino acids in the brain - focus on NMDA receptors
Cotman, C. W., & Iversen, L. L. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90170-6 · Cited by 637
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 620
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577 · cited 2×
“Although it is problematic to extrapolate data from animal studies to complex human diseases such as schizophrenia, these results are compatible with the notion that dysfunctional glutamate NMDA neurotransmission within the PFC, and hyperfunction of 5-HT neuronal systems, are implicated in the pathophysiology of schiz…”
ResultDissociating executive functions of the prefrontal cortex.
Robbins, T. W. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0131 · Cited by 574 · cited 1×
“The prefrontal cortex has been implicated in a variety of cognitive functions, including working memory, visual attention, and executive functions (Shallice, 1982; Fuster, 1989; Corbetta et al, 1991; Duncan, 1995, 2001; Baddeley, 1996; Goldman-Rakic, 1998; Robbins, 1998).”
Dias, R., Robbins, T. W., & Roberts, A. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09285.1997 · Cited by 555 · cited 1×
“The enhanced tendency to perseverate appears to be a distinctive trait of frontal-lesion animals (Mishkin, 1964; Muir et al, 1996; Dias et al, 1997; Ragozzino et al, 1999; Killcross and Coutureau, 2003), and of frontal-lobe patients when required to inhibit previously reinforced responses (Owen et…”
BackgroundRagozzino, M. E., Detrick, S., & Kesner, R. P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04585.1999 · Cited by 553
Granon, S., Passetti, F., Thomas, K. L., Dalley, J. W., Everitt, B. J., & Robbins, T. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01208.2000 · Cited by 546
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
AGHAJANIAN, G. K., & MAREK, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 514
Muir, J. L., Everitt, B. J., & Robbins, T. W. (1996) · Cerebral Cortex · doi:10.1093/cercor/6.3.470 · Cited by 502
Catecholamine regulation of the prefrontal cortex
Arnsten, A. F. T. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100208 · Cited by 488
Harrison, A. A., Everitt, B. J., & Robbins, T. W. (1997) · Psychopharmacology · doi:10.1007/s002130050410 · Cited by 452 · cited 2×
“Previous work has shown that 5-HT lesion of the dorsal raphe (DR) nucleus improves attentional functioning (Harrison et al, 1997b).”
BackgroundVerma, A., & Moghaddam, B. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00373.1996 · Cited by 449
Pyramidical Model of Schizophrenia
Kay, S. R., & Sevy, S. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.537 · Cited by 444
Roberts, A., De Salvia, M., Wilkinson, L., Collins, P., Muir, J., Everitt, B., & Robbins, T. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02531.1994 · Cited by 415
The Mechanism of Action of Novel Antipsychotic Drugs
Meltzer, H. Y. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.263 · Cited by 411
Attention, intelligence, and the frontal lobes.
Duncan, J. (1995) · Cited by 363
Kehne, J. H., Baron, B. M., Carr, A. A., Chaney, S. F., Elands, J., Feldman, D. J., Frank, R. A., van Giersbergen, P. L., McCloskey, T. C., Johnson, M. P., et al. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12956-x · Cited by 358
Martı́n-Ruiz, R., Puig, M. V., Celada, P., Shapiro, D. A., Roth, B. L., Mengod, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09856.2001 · Cited by 339
Honey, G. D., Bullmore, E. T., Soni, W., Varatheesan, M., Williams, S. C. R., & Sharma, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13432 · Cited by 288
Dalley, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00412-2 · Cited by 272
Roth, B., Hanizavareh, S. M., & Blum, A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1683-8 · Cited by 257
Lehmann, J., Schneider, J., McPherson, S., Murphy, D. E., Bernard, P., Tsai, C., Bennett, D. A., Pastor, G., Steel, D. J., & Boehm, C. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00366-0 · Cited by 237
Winstanley, C. A., Chudasama, Y., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1398-x · Cited by 234 · cited 4×
“…of 5-HT2A receptors by a variety of nonselective 5-HT2A agonists increased while 5-HT2A receptor antagonists reduced anticipatory responses (Carli and Samanin, 1992; Ruotsalainen et al, 1997; Koskinen et al, 2000; Koskinen and Sirvio, 2001; Winstanley et al, 2003; Passetti et al, 2003a).”
BackgroundMethodInfluentialPassetti, F. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.12.1254 · Cited by 223
Gleason, S. D., & Shannon, H. E. (1997) · Psychopharmacology · doi:10.1007/s002130050165 · Cited by 216
Puumala, T., & Sirviö, J. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00392-8 · Cited by 202
Varty, G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00072-4 · Cited by 202
Jakab, R. L., & Goldman, P. S. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000214)417:3<337::aid-cne7>3.0.co;2-o · Cited by 197
Can the neuropsychological case-study approach be applied to schizophrenia?
Shallice, T., Burgess, P. W., & Frith, C. D. (1991) · Psychological Medicine · doi:10.1017/s0033291700022303 · Cited by 186
霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位
Jakab, R. L., & Goldman‐Rakic, P. S. (1998) · Cited by 182
Higgins, G. A., Enderlin, M., Haman, M., & Fletcher, P. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1549-0 · Cited by 179 · cited 5×
“This dose is similar to the ED50 of 30 mg/kg reported to block dizocilpine-induced hyperactivity in rats (Higgins et al, 2004).”
BackgroundMethodResultInfluentialMiyamoto, Y., Yamada, K., Noda, Y., Mori, H., Mishina, M., & Nabeshima, T. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00750.2001 · Cited by 167
Scruggs, J. L., Patel, S., Bubser, M., & Deutch, A. Y. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08846.2000 · Cited by 165
THE PREFRONTAL CORTEXEXECUTIVE AND COGNITIVE FUNCTIONS.
Gerhand, S. (1999) · Brain · doi:10.1093/brain/122.5.994 · Cited by 164
ROMANIDES, A., Duffy, P., & Kalivas, P. W. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00747-7 · Cited by 161
Harvey, P. D., Green, M. F., McGurk, S. R., & Meltzer, H. Y. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1342-5 · Cited by 156
O'Neill, K. A., & Liebman, J. M. (1987) · Brain Research · doi:10.1016/0006-8993(87)91628-3 · Cited by 155
Visual Attention and Cortical Circuits
(2001) · The MIT Press eBooks · doi:10.7551/mitpress/7125.001.0001 · Cited by 150
Liégeois, J.-F., Ichikawa, J., & Meltzer, H. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02620-3 · Cited by 145
Scruggs, J. L., Schmidt, D. E., & Deutch, A. Y. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00547-0 · Cited by 138
Passetti, F., Dalley, J. W., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1227-7 · Cited by 121
Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats
Martin, P., Carlsson, M. L., & Hjorth, S. (1998) · Neuroreport · doi:10.1097/00001756-199809140-00012 · Cited by 119
Higgins, G. A., Ballard, T. M., Huwyler, J., Kemp, J. A., & Gill, R. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00402-1 · Cited by 113
Harrison, A. A., Everitt, B. J., & Robbins, T. W. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00053-3 · Cited by 110
Specific Neuropsychological Deficits in Schizophrenic Patients with Preserved Intellectual Function
Elliott, R., McKenna, P. J., Robbins, T. W., & Sahakian, B. J. (1998) · Cognitive Neuropsychiatry · doi:10.1080/135468098396242 · Cited by 110
Koskinen, T., Ruotsalainen, S., Puumala, T., Lappalainen, R., Koivisto, E., Männistö, P. T., & Sirviö, J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00159-8 · Cited by 108 · cited 3×
“…of 5-HT2A receptors by a variety of nonselective 5-HT2A agonists increased while 5-HT2A receptor antagonists reduced anticipatory responses (Carli and Samanin, 1992; Ruotsalainen et al, 1997; Koskinen et al, 2000; Koskinen and Sirvio, 2001; Winstanley et al, 2003; Passetti et al, 2003a).”
BackgroundJentsch, J. D., Tran, A., Taylor, J. R., & Roth, R. H. (1998) · Psychopharmacology · doi:10.1007/s002130050649 · Cited by 97
Carli, M., & SAMANIN, R. (1992) · Psychopharmacology · doi:10.1007/bf02801977 · Cited by 95
Harvey, P. D., SIU, C. O., & Romano, S. J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1652-2 · Cited by 93
Dissociating executive functions of the prefrontal cortex
Robbins, T. W. (1998) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198524410.003.0009 · Cited by 88
Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia
Le Pen, G., Grottick, A. J., Higgins, G. A., & Moreau, J.-L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300208 · Cited by 82
Bonaccorso, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00311-1 · Cited by 80
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
Martin, P., Waters, N., Waters, N., Carlsson, A., & Carlsson, M. L. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01188-6 · Cited by 77
Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions
Passetti, F., Levita, L., & Robbins, T. W. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00229-2 · Cited by 75
Wesierska, M., González, R. M., & Burešs, J. (1990) · Behavioral Neuroscience · doi:10.1037//0735-7044.104.1.74 · Cited by 73
MONITORING MOLECULES IN NEUROSCIENCE
Jongsma, M., Bosker, F. J., Cremers, T. I. H. F., van der Hart, M., Flik, G., Westerink, B. H. C., & Boer, D. J. (1994) · Cited by 69
Ruotsalainen, S., Sirviö, J., Jäkälä, P., Puumala, T., MacDonald, E., & Riekkinen, P. J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00389-6 · Cited by 62
Koskinen, T., & Sirviö, J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00425-1 · Cited by 58
Schizophrenia, training paradigms, and the Wisconsin Card Sorting Test redux
Goldberg, T. L., & Weinberger, D. R. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90024-8 · Cited by 58
Aura, J., & Riekkinen, P. (1999) · Neuroreport · doi:10.1097/00001756-199902050-00008 · Cited by 55
Corbett, R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00128-1 · Cited by 44
Habara, T., Hamamura, T., Miki, M., Ohashi, K., & Kuroda, S. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00926-8 · Cited by 27
Perseverative structuring of responses by schizophrenic and affective disorder patients
Lyon, N., & Gerlach, J. (1988) · Journal of Psychiatric Research · doi:10.1016/0022-3956(88)90035-0 · Cited by 23
Frontal Lobe Function and the Control of Visual Attention
Duncan, J. (2001) · The MIT Press eBooks · doi:10.7551/mitpress/7125.003.0006 · Cited by 5
Research works printed but not linked: 2
- Fuster JM (1989). The Prefrontal Cortex, 2nd edn. Raven Press: New York.
- Mishkin M (1964). Perseveration of central sets after frontal lesions in monkeys. In: Akert K (ed). The Frontal Granular Cortex and Behaviour. McGraw-Hill: New York.
Cited by
The neuropharmacology of impulsive behaviour
PATTIJ, T., & VANDERSCHUREN, L. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.002 · Cited by 473
Serotonin and Prefrontal Cortex Function: Neurons, Networks, and Circuits
Puig, M. V., & Gulledge, A. T. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8214-0 · Cited by 421
“In rats, where more invasive experiments can be implemented, both stimulation of 5-HT1A receptors or blockade of 5HT2A receptors in the PFC abolished attentional impairments induced by the NMDA receptor antagonist CPP [171, 172].”
BackgroundThe role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 382
“Fear conditioning taxes a well-defined neural circuit within the amygdala, which in turn interacts with the hippocampus, anterior cingulate, or the PFC, depending on the elements of the conditioning session and the stage of memory processing (Zelikowsky et al., 2014).”
BackgroundInfluentialCarli, M., Baviera, M., Invernizzi, R. W., & Balducci, C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300893 · Cited by 187
“Interestingly, opposite behavioral effects of 8-OH-DPAT were often reported depending on whether the drug was administered directly into the DR or into its projecting areas (Carli et al, 1995, 1998; Warburton et al, 1997).”
BackgroundResultInfluentialSelf-citationPerry, J. L., Joseph, J. E., Jiang, Y., Zimmerman, R. S., Kelly, T. H., Darna, M., Huettl, P., Dwoskin, L. P., & Bardo, M. T. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.09.001 · Cited by 180
Metadata
- Authors
- Mirjana, C., Baviera, M., Invernizzi, R. W., & Balducci, C.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Venue
- Neuropsychopharmacology
- Published
- 2004-05-05
- Volume
- 29
- Issue
- 9
- Pages
- 1637-1647
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2044977985
- Cited by
- 102
- References
- 93
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 8 · 2014: 6 · 2013: 4 · 2012: 10
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Update notices
- erratum (2004-12-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca (RBAU01ZS5C)
- Ministero dell'Università e della Ricerca
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- 5-HT2A receptor antagonism, M100907, NMDA receptor blockade, CPP, attentional performance, sustained visual attention, divided attention, medial prefrontal cortex, executive function, perseverative responding, motor hyperactivity, glutamate, serotonin
- MeSH terms
- Animals, Attention, Dose-Response Relationship, Drug, Fluorobenzenes, Injections, Subcutaneous, Male, Microinjections, Motor Activity, Piperazines, Piperidines, Psychomotor Performance, Reaction Time, Serial Learning, Serotonin Antagonists, Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex, Excitatory Amino Acid Antagonists, Receptor, Serotonin, 5-HT2A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.